nach oben

Erschienen in:

03.05.2019 | Clinical Study

Satellite lesions of DNET: implications for seizure and tumor control after resection

verfasst von: Jeyul Yang, Seung-Ki Kim, Ki Joong Kim, Jong Hee Chae, Byung Chan Lim, Kyu-Chang Wang, Sung-Hye Park, Ji Hoon Phi

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Dysembryoplastic neuroepithelial tumors (DNETs) are a common cause of chronic drug-resistant epilepsy and are known for their favorable surgical outcomes. Nevertheless, the seizure recurrence-free rate is not as favorable if tumorous nodules are present near the main mass. We call these small tumorous nodules in the vicinity of the main mass satellite lesions (SLs). We analyzed tumor and seizure control in the presence and following the subsequent removal of SLs.

Methods

We retrospectively reviewed the medical records, radiological data, and surgical procedures to obtain the outcomes of children who underwent resection surgery for DNET. The analyses were designed to address the associations among the demographic, tumor and seizure-related variables. A Cox proportional hazard model was used for the univariate and multivariate analyses.

Results

In total, 39 consecutive patients were included (26 males and 13 females). SLs were found in 22 patients (56%). The year-to-year analysis of patients with Engel class I was approximately 80% during the follow-up period. However, the actual seizure recurrence-free survival (RFS) rate was 82, 73 and 70% at the first, second and fifth year, respectively. The patients who initially presented with SLs had 46% seizure recurrence rates, while those without SL had 18% seizure recurrence rates.

Conclusions

As the seizure-RFS rate significantly declines over time, a more accurate seizure-free rate analysis using survival curves could be important for determining the outcome of DNET surgery. A thorough review identifying satellite lesions preoperatively and using intraoperative neuronavigation, electrocorticography (ECoG) or intraoperative ultrasonography is warranted to accomplish the wide resection of tumors with accompanying satellite lesions.

Blumcke I, Spreafico R, Haaker G, Coras R, Kobow K, Bien CG, Pfafflin M, Elger C, Widman G, Schramm J, Becker A, Braun KP, Leijten F, Baayen JC, Aronica E, Chassoux F, Hamer H, Stefan H, Rossler K, Thom M, Walker MC, Sisodiya SM, Duncan JS, McEvoy AW, Pieper T, Holthausen H, Kudernatsch M, Meencke HJ, Kahane P, Schulze-Bonhage A, Zentner J, Heiland DH, Urbach H, Steinhoff BJ, Bast T, Tassi L, Lo Russo G, Ozkara C, Oz B, Krsek P, Vogelgesang S, Runge U, Lerche H, Weber Y, Honavar M, Pimentel J, Arzimanoglou A, Ulate-Campos A, Noachtar S, Hartl E, Schijns O, Guerrini R, Barba C, Jacques TS, Cross JH, Feucht M, Muhlebner A, Grunwald T, Trinka E, Winkler PA, Gil-Nagel A, Toledano Delgado R, Mayer T, Lutz M, Zountsas B, Garganis K, Rosenow F, Hermsen A, von Oertzen TJ, Diepgen TL, Avanzini G, Consortium E (2017) Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med 377(17):1648–1656. https://doi.org/10.1056/nejmoa1703784 CrossRefPubMed

Luyken C, Blumcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, Schramm J (2003) The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 44(6):822–830PubMed

Fried I, Kim JH, Spencer DD (1994) Limbic and neocortical gliomas associated with intractable seizures: a distinct clinicopathological group. Neurosurgery 34(5):815–824PubMed

Maria T, Ingmar B, Eleonora A (2012) Long-term epilepsy-associated tumors. Brain Pathol 22(3):350–379. https://doi.org/10.1111/j.1750-3639.2012.00582.x CrossRef

Daumas-Duport C, Scheithauer BW, Chodkiewicz J-P, Laws JER, Vedrenne C (1988) Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizuresreport of thirty-nine cases. Neurosurgery 23(5):545–556. https://doi.org/10.1227/00006123-198811000-00002 CrossRefPubMed

Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820PubMed

Bonney PA, Boettcher LB, Conner AK, Glenn CA, Briggs RG, Santucci JA, Bellew MR, Battiste JD, Sughrue ME (2016) Review of seizure outcomes after surgical resection of dysembryoplastic neuroepithelial tumors. J Neurooncol 126(1):1–10. https://doi.org/10.1007/s11060-015-1961-4 CrossRefPubMed

Nguyen HS, Doan N, Gelsomino M, Shabani S (2017) Dysembryoplastic neuroectodermal tumor: an analysis from the Surveillance, Epidemiology, and End Results Program, 2004–2013. World Neurosurgery 103:380–385. https://doi.org/10.1016/j.wneu.2017.04.093 CrossRefPubMed

Zhang J-g Hu, W-z Zhao R-j, L-f Kong (2014) Dysembryoplastic neuroepithelial tumor: a clinical, neuroradiological, and pathological study of 15 cases. J Child Neurol 29(11):1441–1447. https://doi.org/10.1177/0883073813490831 CrossRefPubMed

10.

Santos MV, de Oliveira RS, Machado HR (2014) Approach to cortical dysplasia associated with glial and glioneuronal tumors (FCD type IIIb). Child’s Nervous System 30(11):1869–1874. https://doi.org/10.1007/s00381-014-2519-z CrossRefPubMed

11.

Daghistani R, Miller E, Kulkarni AV, Widjaja E (2013) Atypical characteristics and behavior of dysembryoplastic neuroepithelial tumors. Neuroradiology 55(2):217–224. https://doi.org/10.1007/s00234-013-1135-z CrossRefPubMed

12.

Maher CO, White JB, Scheithauer BW, Raffel C (2008) Recurrence of dysembryoplastic neuroepithelial tumor following resection. Pediatr Neurosurg 44(4):333–336PubMed

13.

Yasargil MG (1984) Microneurosurgery: operative treatment of CNS tumors 4A. Thieme Stratton, New York

14.

Kim YH, Kim JS, Lee SK, Chung CK (2017) Neurologic outcome after resection of parietal lobe including primary somatosensory cortex: implications of additional resection of posterior parietal cortex. World Neurosurg 106:884–890. https://doi.org/10.1016/j.wneu.2017.07.066 CrossRefPubMed

15.

Engel J Jr (1993) Outcome with respect to epileptic seizures. In: Engel J Jr (ed) Surgical treatment of the epilepsies. Raven Press, New York, pp 609–621

16.

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE commission on therapeutic strategies. Epilepsia 51(6):1069–1077PubMed

17.

Sampetrean O, Maehara T, Arai N, Nemoto T (2006) Rapidly growing dysembryoplastic neuroepithelial tumorcase report. Neurosurgery 59(6):E1337–E1338. https://doi.org/10.1227/01.NEU.0000245621.62721.79 CrossRefPubMed

18.

Chao L, Tao XB, Jun YK, Xia HH, Wan WK, Tao QS (2013) Recurrence and histological evolution of dysembryoplastic neuroepithelial tumor: a case report and review of the literature. Oncol Lett 6(4):907–914PubMedPubMedCentral

19.

Nadi M, Ahmad T, Huang A, Hawkins C, Bouffet E, Kulkarni AV (2016) Atypical teratoid rhabdoid tumor diagnosis after partial resection of dysembryoplastic neuroepithelial tumor: case report and review of the literature. Pediatr Neurosurg 51(4):191–198PubMed

20.

Ray WZ, Blackburn SL, Casavilca-Zambrano S, Barrionuevo C, Orrego JE, Heinicke H, Dowling JL, Perry A (2009) Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature. J Neurooncol 94(2):283. https://doi.org/10.1007/s11060-009-9849-9 CrossRefPubMed

21.

Stokland T, Liu J-F, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro-Oncology 12(12):1257–1268. https://doi.org/10.1093/neuonc/noq092 CrossRefPubMedPubMedCentral

22.

Nolan M, Sakuta R, Chuang N, Otsubo H, Rutka J, Or Snead, Hawkins C, Weiss S (2004) Dysembryoplastic neuroepithelial tumors in childhood long-term outcome and prognostic features. Neurology 62(12):2270–2276PubMed

23.

Chassoux F, Rodrigo S, Mellerio C, Landre E, Miquel C, Turak B, Laschet J, Meder JF, Roux FX, Daumas-Duport C, Devaux B (2012) Dysembryoplastic neuroepithelial tumors: an MRI-based scheme for epilepsy surgery. Neurology 79(16):1699–1707. https://doi.org/10.1212/WNL.0b013e31826e9aa9 CrossRefPubMed

24.

Chang EF, Christie C, Sullivan JE, Garcia PA, Tihan T, Gupta N, Berger MS, Barbaro NM (2010) Seizure control outcomes after resection of dysembryoplastic neuroepithelial tumor in 50 patients. J Neurosurg Pediatr 5(1):123–130PubMed

25.

Sakuta R, Otsubo H, Nolan MA, Weiss SK, Hawkins C, Rutka JT, Chuang NA, Chuang SH, Carter Snead O (2004) Recurrent intractable seizures in children with cortical dysplasia adjacent to dysembryoplastic neuroepithelial tumor. J Child Neurol 19(3):377–384

26.

Qaddoumi I, Ellison DW, Morris EB, Broniscer A, Boop F, Merchant T, Palmer SL, Gajjar A (2010) Dysembryoplastic neuroepithelial tumors and cognitive outcome. Cancer 116(23):5461–5469. https://doi.org/10.1002/cncr.25528 CrossRefPubMedPubMedCentral

27.

Haydon DH, Dahiya S, Smyth MD, Limbrick DD, Leonard JR (2014) Greater extent of resection improves ganglioglioma recurrence-free survival in children: a volumetric analysis. Neurosurgery 75(1):37–42. https://doi.org/10.1227/neu.0000000000000349 CrossRefPubMed

28.

Ranger A, Diosy D (2015) Seizures in children with dysembryoplastic neuroepithelial tumors of the brain—a review of surgical outcomes across several studies. Child’s Nervous System 31(6):847–855. https://doi.org/10.1007/s00381-015-2675-9 CrossRefPubMedPubMedCentral

29.

Bilginer B, Yalnızoglu D, Soylemezoglu F, Turanlı G, Cila A, Topçu M, Akalan N (2008) Surgery for epilepsy in children with dysembryoplastic neuroepithelial tumor: clinical spectrum, seizure outcome, neuroradiology, and pathology. Child’s Nervous System 25(4):485. https://doi.org/10.1007/s00381-008-0762-x CrossRefPubMed

30.

Francine C, Catherine D-D (2013) Dysembryoplastic neuroepithelial tumors: where are we now? Epilepsia 54(s9):129–134. https://doi.org/10.1111/epi.12457 CrossRef

31.

Englot DJ, Berger MS, Barbaro NM, Chang EF (2012) Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia 53(1):51–57. https://doi.org/10.1111/j.1528-1167.2011.03269.x CrossRefPubMed

32.

Thom M, Toma A, An S, Martinian L, Hadjivassiliou G, Ratilal B, Dean A, McEvoy A, Sisodiya SM, Brandner S (2011) One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol 70(10):859–878. https://doi.org/10.1097/NEN.0b013e3182302475 CrossRefPubMed

33.

Giulioni M, Rubboli G, Marucci G, Martinoni M, Volpi L, Michelucci R, Marliani AF, Bisulli F, Tinuper P, Castana L, Sartori I, Calbucci F (2009) Seizure outcome of epilepsy surgery in focal epilepsies associated with temporomesial glioneuronal tumors: lesionectomy compared with tailored resection. J Neurosurg 111(6):1275–1282. https://doi.org/10.3171/2009.3.Jns081350 CrossRefPubMed

34.

Nitin T, Yoshua E (2013) Resection strategies in tumoral epilepsy: is a lesionectomy enough? Epilepsia 54(s9):72–78. https://doi.org/10.1111/epi.12448 CrossRef

35.

André P, Eliseu P, Duval SV (2013) Developmental tumors and adjacent cortical dysplasia: single or dual pathology? Epilepsia 54(s9):18–24. https://doi.org/10.1111/epi.12438 CrossRef

36.

Rivera B, Gayden T, Carrot-Zhang J, Nadaf J, Boshari T, Faury D, Zeinieh M, Blanc R, Burk DL, Fahiminiya S, Bareke E, Schuller U, Monoranu CM, Strater R, Kerl K, Niederstadt T, Kurlemann G, Ellezam B, Michalak Z, Thom M, Lockhart PJ, Leventer RJ, Ohm M, MacGregor D, Jones D, Karamchandani J, Greenwood CM, Berghuis AM, Bens S, Siebert R, Zakrzewska M, Liberski PP, Zakrzewski K, Sisodiya SM, Paulus W, Albrecht S, Hasselblatt M, Jabado N, Foulkes WD, Majewski J (2016) Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors. Acta Neuropathol 131(6):847–863. https://doi.org/10.1007/s00401-016-1549-x CrossRefPubMedPubMedCentral

37.

Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD, Tang B, Haupfear K, Punchihewa C, Easton J (2016) Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol 131(6):833–845PubMedPubMedCentral

38.

Blümcke I, Aronica E, Becker A, Capper D, Coras R, Honavar M, Jacques TS, Kobow K, Miyata H, Mühlebner A (2016) Low-grade epilepsy-associated neuroepithelial tumours—the 2016 WHO classification. Nat Rev Neurol 12(12):732PubMed

39.

Lee JH, Huynh M, Silhavy JL, Kim S, Dixon-Salazar T, Heiberg A, Scott E, Bafna V, Hill KJ, Collazo A (2012) De novo somatic mutations in components of the PI3 K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 44(8):941PubMedPubMedCentral

40.

Lim JS, W-i Kim, Kang H-C, Kim SH, Park AH, Park EK, Cho Y-W, Kim S, Kim HM, Kim JA (2015) Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med 21(4):395

Titel: Satellite lesions of DNET: implications for seizure and tumor control after resection
verfasst von: Jeyul Yang
Seung-Ki Kim
Ki Joong Kim
Jong Hee Chae
Byung Chan Lim
Kyu-Chang Wang
Sung-Hye Park
Ji Hoon Phi
Publikationsdatum: 03.05.2019
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2019
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-019-03174-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Applicability and limitations of a recently-proposed prognostic grading metric, initial brain metastasis velocity, for brain metastasis patients undergoing stereotactic radiosurgery

Effect of patient age on glioblastoma perioperative treatment costs: a value driven outcome database analysis

Fronto-limbic white matter microstructure, behavior, and emotion regulation in survivors of pediatric brain tumor

Comparative analysis of intracranial meningiomas in patients younger than 40 years

Fucosyltransferase 4 and 7 mediates adhesion of non-small cell lung cancer cells to brain-derived endothelial cells and results in modification of the blood–brain-barrier: in vitro investigation of CD15 and CD15s in lung-to-brain metastasis